Search

Long-acting injectable (LAI) formulations of antiretrovirals (ARVs) as pre-exposure prophylaxis (PrEP) could be an attractive alternative for men who have sex with men (MSM) who are interested in ARV-based biomedical prevention but will not use a daily pill. This study investigated interest in LAI-PrEP in a cohort of MSM in China and characterized how MSM willing to use only injectable PrEP differed from MSM who would use PrEP regardless of modality or not at all. Demographic, behavioral, and risk perception measures were collected and associations investigated. A licensed LAI-PrEP agent would increase the proportion interested in PrEP by 24.5% over oral PrEP alone. Combining interest in oral and injectable PrEP, 78.5% of the sample could be covered if reported interest in PrEP translated into actual uptake. Partnership factors differentiated those who would be willing to use only LAI-PrEP versus any PrEP modality, while higher self-perception of risk was associated with interest in LAI-PrEP versus no PrEP. The addition of a second PrEP modality could yield increased population coverage of PrEP. Social and behavioral research should be undertaken in parallel with clinical development of injectable PrEP agents to identify characteristics of those who are not interested in oral PrEP but would take advantage of ARV-based prevention with the introduction of an injectable product.

: Introduction: Sexual and gender minority populations are disproportionately affected by the global syndemic of HIV and other sexually transmitted infections (STIs). We hypothesized that transgender women (TGW) and non‐binary individuals in Nigeria have more STIs than cis‐gender men who have sex with men (cis‐MSM), and that experiences of stigma and sexual practices differ between these three groups. Methods: From 2013 to 2020, TRUST/RV368 enrolled adults assigned male sex at birth who reported anal sex with men in Abuja and Lagos, Nigeria. Participants were tested for STIs and completed questionnaires about sexual behaviours and social stigma every 3 months. Participants were categorized as cis‐MSM, TGW or non‐binary/other based on self‐reported gender identity. Gender group comparisons were made of HIV, gonorrhoea and chlamydia prevalence and incidence; stigma indicators; and condom use during anal sex. Results: Among 2795 participants, there were 2260 (80.8%) cis‐MSM, 284 (10.2%) TGW and 251 (9.0%) non‐binary/other individuals with median age of 23 years (interquartile range 20–27). HIV prevalence among cis‐MSM, TGW and non‐binary/other participants was 40.8%, 51.5% and 47.6%, respectively (p = 0.002). HIV incidence was 8.7 cases per 100 person‐years (PY) (95% confidence interval [CI] 6.9–10.8), 13.1 cases/100 PY (95% CI 6.5–23.4) and 17.6 cases/100 PY (95% CI 9.8–29.0, p = 0.025), respectively. Anorectal gonorrhoea incidence was lower in cis‐MSM than TGW (22.2 [95% CI 19.6–25.0] vs. 35.9 [95% CI 27.3–46.3]). TGW were more likely than cis‐MSM to report being affected by stigma, including assault (47.2% vs. 32.3%), fear of walking around (32.4% vs. 19.2%) and healthcare avoidance (25.0% vs. 19.1%; all p < 0.05). TGW were more likely to report always using condoms than non‐binary/other individuals (35.3% vs. 26.2%, p = 0.041) during receptive anal sex. Conclusions: Sexual and gender minorities in Nigeria have heterogeneous sexual behaviours and experiences of social stigma that may influence the vulnerability to HIV and other STIs. There is a need for tailored interventions that acknowledge and are informed by gender. Further research is needed, particularly among understudied non‐binary individuals, to better understand disparities and inform tailored interventions to improve outcomes among these communities., INTRODUCTION At least 25% of the global burden of HIV is borne by individuals who are sexual or gender minorities, which include individuals who identify as lesbian, gay, bisexual, asexual, [...]

We present basic properties and discuss potential insurance applications of a new class of probability distributions on positive integers with power law tails. The distributions in this class are zero-inflated discrete counterparts of the Pareto distribution. In particular, we obtain the probability of ruin in the compound binomial risk model where the claims are zero-inflated discrete Pareto distributed and correlated by mixture.

Flexible humidity sensors with high sensitivity, fast response time, and outstanding reliability have the potential to revolutionize electronic skin, healthcare, and non-contact sensing. In this study, we employed a straightforward nanocluster deposition technique to fabricate a resistive humidity sensor on a flexible substrate, using molybdenum oxide nanoparticles (MoOx NPs). We systematically evaluated the humidity-sensing behaviors of the MoOx NP film-based sensor and found that it exhibited exceptional sensing capabilities. Specifically, the sensor demonstrated high sensitivity (18.2 near zero humidity), a fast response/recovery time (1.7/2.2 s), and a wide relative humidity (RH) detection range (0–95%). The MoOx NP film, with its closely spaced granular nanostructure and high NP packing density, exhibited insensitivity to mechanical deformation, small hysteresis, good repeatability, and excellent stability. We also observed that the device exhibited distinct sensing kinetics in the range of high and low RH. Specifically, for RH > 43%, the response time showed a linear prolongation with increased RH. This behavior was attributed to two factors: the higher physical adsorption energy of H2O molecules and a multilayer physical adsorption process. In terms of applications, our sensor can be easily attached to a mask and has the potential to monitor human respiration owing to its high sensing performance. Additionally, the sensor was capable of dynamically tracking RH changes surrounding human skin, enabling a non-contact sensing capability. More significantly, we tested an integrated sensor array for its ability to detect moisture distribution in the external environment, demonstrating the potential of our sensor for contactless human–machine interaction. We believe that this innovation is particularly valuable during the COVID-19 epidemic, where cross-infection may be averted by the extensive use of contactless sensing. Overall, our findings demonstrate the tremendous potential of MoOx NP-based humidity sensors for a variety of applications, including healthcare, electronic skin, and non-contact sensing. [ABSTRACT FROM AUTHOR]

Background: HIV and hepatitis C virus (HCV) have shared routes of transmission among men who have sex with men (MSM). Routine testing facilitates early diagnosis and treatment, thereby preventing morbidity and onward transmission. We evaluated factors associated with HIV and HCV testing in a behaviorally vulnerable cohort of predominantly MSM. Methods: From June 2018 through June 2019, the BRAHMS study enrolled adults at ten German outpatient clinics that serve gender and sexual minority populations. Participants completed behavioral questionnaires that captured prior experience with HIV and HCV testing. Multivariable robust Poisson regression was used to evaluate factors potentially associated with testing in the previous 6 months. Results: Among 1017 participants with median age 33 (interquartile range 28–39) years, 1001 (98.4%) reported any lifetime history of HIV testing and 787 (77.4%) reported any HCV testing, including 16 (1.6%) known to be living with HCV. Testing within the last 6 months was reported by 921 (90.6%) and 513 (50.4%) for HIV and HCV, respectively. Recent HIV testing was more common among participants with higher education level and recent HCV testing. Recent HCV testing was more common among participants with non-cisgender identity, lifetime history of illicit drug use, hepatitis B immunity or infection, and recent HIV testing. Conclusion: Prior testing for HIV was common in this cohort, but interventions are needed to improve HCV risk stratification and access to testing. HIV testing infrastructure can be successfully leveraged to support HCV testing, but differentiated preventive care delivery is needed for some vulnerable populations. [ABSTRACT FROM AUTHOR]

Elevated atmospheric CO2 (eCO2) generally increases carbon input in rice paddy soils and stimulates the growth of methane‐producing microorganisms. Therefore, eCO2 is widely expected to increase methane (CH4) emissions from rice agriculture, a major source of anthropogenic CH4. Agricultural practices strongly affect CH4 emissions from rice paddies as well, but whether these practices modulate effects of eCO2 is unclear. Here we show, by combining a series of experiments and meta‐analyses, that whereas eCO2 strongly increased CH4 emissions from paddies without straw incorporation, it tended to reduce CH4 emissions from paddy soils with straw incorporation. Our experiments also identified the microbial processes underlying these results: eCO2 increased methane‐consuming microorganisms more strongly in soils with straw incorporation than in soils without straw, with the opposite pattern for methane‐producing microorganisms. Accounting for the interaction between CO2 and straw management, we estimate that eCO2 increases global CH4 emissions from rice paddies by 3.7%, an order of magnitude lower than previous estimates. Our results suggest that the effect of eCO2 on CH4 emissions from rice paddies is smaller than previously thought and underline the need for judicious agricultural management to curb future CH4 emissions. [ABSTRACT FROM AUTHOR]

BACKGROUND: Silicone tracheobronchial stent insertion can provide symptomatic relief through airway stabilization in patients with symptomatic tracheobronchomalacia. However, there are few studies on this method. OBJECTIVE: To evaluate the safety and efficacy of silicone stents in the treatment of tracheobronchomalacia. METHODS: Eight tracheobronchomalacia patients who underwent silicone stent implantation at Henan Provincial People's Hospital between September 2015 and December 2018 were included in this study. According to the location and degree of airway softening, appropriate silicone stents were designed. Silicone stents were implanted in all eight patients, including hourglass stents in 2 cases, straight tube stents in 2 patients, Y -shaped stents in 3 patients, and T -shaped stents in 1 patient. All patients provided informed consent and this study was approved by the Medical Ethics Committee of Henan Provincial People's Hospital, China. Blood gas analysis was performed before and 30 days after surgery to measure blood oxygen level. Quality of life was assessed by card score. The position of stent, intraluminal endocrine, and granulation growth were dynamically monitored by bronchoscopy at 7, 30 and 60 days after surgery. RESULTS AND CONCLUSION: Silicone airway stents were placed successfully in seven patients. Dyspnea was relieved immediately. One patient had rupture of left main bronchial membrane during the procedure of insertion. The partial oxygen pressure and chi-square score of seven patients at 30 days after surgery were significantly higher than those before surgery (t=-8.60, -20.76, P < 0.05}. Tracheoscopy revealed that stent displacement occurred in 3 patients, difficulty in sputum expectoration and mild granulation tissue hyperplasia occurred in 3 patients, and improved after endoscopic treatment. The results suggest that silicone stent insertion in patients with tracheobronchomalacia can alleviate the symptoms of patients. Although the incidence of silicone stent displacement and sputum obstruction is high, silicone stent insertion is still an important treatment method. [ABSTRACT FROM AUTHOR]